Dormancy and NKG2D system in brain metastases: Analysis of immunogenicity

por Flüh, Charlotte, Mafael, Victor, Adamski, Vivian, Synowitz, Michael, Held-Feindt, Janka
Publicado 2020

The Chemokine Receptor CXCR6 Evokes Reverse Signaling via the Transmembrane Chemokine CXCL16

por Adamski, Vivian, Mentlein, Rolf, Lucius, Ralph, Synowitz, Michael, Held-Feindt, Janka, Hattermann, Kirsten
Publicado 2017

Isolation and Characterization of Fast-Migrating Human Glioma Cells in the Progression of Malignant Gliomas

por Adamski, Vivian, Schmitt, Anne Dorothée, Flüh, Charlotte, Synowitz, Michael, Hattermann, Kirsten, Held-Feindt, Janka
Publicado 2017

Dormant glioblastoma cells acquire stem cell characteristics and are differentially affected by Temozolomide and AT101 treatment

por Adamski, Vivian, Hempelmann, Annika, Flüh, Charlotte, Lucius, Ralph, Synowitz, Michael, Hattermann, Kirsten, Held-Feindt, Janka
Publicado 2017

AT101-Loaded Cubosomes as an Alternative for Improved Glioblastoma Therapy

por Flak, Dorota K, Adamski, Vivian, Nowaczyk, Grzegorz, Szutkowski, Kosma, Synowitz, Michael, Jurga, Stefan, Held-Feindt, Janka
Publicado 2020

Entry and exit of chemotherapeutically-promoted cellular dormancy in glioblastoma cells is differentially affected by the chemokines CXCL12, CXCL16, and CX3CL1

por Adamski, Vivian, Hattermann, Kirsten, Kubelt, Carolin, Cohrs, Gesa, Lucius, Ralph, Synowitz, Michael, Sebens, Susanne, Held-Feindt, Janka
Publicado 2020